publication date: Sep. 6, 2019

In Brief

Cance named American Cancer Society chief medical and scientific officer 

William G. Cance  was named the American Cancer Society’s chief medical and scientific officer. 

The society said Cance will lead the integration of the ACS research and cancer control departments, unifying its intramural and extramural research; prevention and early detection; patient and caregiver support and service strategies; global cancer control; and health systems engagement programs.

“Dr. Cance brings to the American Cancer Society impressive breadth and depth of experience as an executive leader, practicing surgical oncologist, researcher, and entrepreneur,” Gary Reedy, ACS CEO, said in a statement. “His work will be critical as we aggressively pursue our 2035 challenge goal to reduce cancer mortality by 40 percent.”

Since 2016, Cance has served as deputy director and, more recently, interim director of the University of Arizona Comprehensive Cancer Center. He has also been a professor in the departments of Interdisciplinary Oncology, Pharmacology & Toxicology, and Surgery for the UA Colleges of Medicine and Pharmacy in Phoenix.

“There are so many reasons why I chose the American Cancer Society,” Cance said in a statement. “The history, the research teams, the mission, the volunteers and the visionary leadership are a great fit. I’m honored and excited for the opportunity. The ACS name has been synonymous with progress and hope. My goal is to more rapidly implement the emerging advances in cancer prevention and treatment to patient care and to help this historic organization achieve its mission to further reduce the burden of cancer nationwide and globally.”

Cance has an active surgical oncology practice, and he is the principal investigator for a 25-year NCI grant to study focal adhesion kinase. He … Continue reading Cance named American Cancer Society chief medical and scientific officer

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.